Enveric Biosciences Reports New Brain Activity Data for Psychedelic-Derived Drug Candidate
New preclinical findings suggest EB-003 can alter brain activity without producing some of the adverse neurological effects observed with DMT ...
New preclinical findings suggest EB-003 can alter brain activity without producing some of the adverse neurological effects observed with DMT ...
US biotechnology company Enveric Biosciences has reported encouraging laboratory results for EB-003, an experimental psychiatric medicine designed to promote neuroplasticity ...
A growing body of research has suggested that meditation and psychedelic medicines may share more in common than previously believed. ...
For much of the past five years, the psychedelic medicine sector has been driven by a relatively straightforward investment thesis. ...
© 2026 Psychedelics.media - A division of Dot Media Corp.
© 2026 Psychedelics.media - A division of Dot Media Corp.